Calvin Aubrey

Calvin Aubrey is a Senior Associate on BroadOak’s growth capital investing team where he specializes in portfolio management and investment execution. Prior to joining BroadOak in 2025, Calvin worked for ARCHIMED where he focused on life sciences, pharmaceutical services, and medical devices investing, and for the Healthcare Investment Banking and Leveraged Finance teams at J.P. Morgan, where he advised on M&A and capital raising transactions. Calvin also has nutraceutical and biotechnology industry experience.

Calvin earned a M.S. in Biotechnology, as well as a B.S. in Finance and International Business from Georgetown University.